Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre-and post-clinical pharmacists' interventional study

BMJ Open

Volumn 2, Issue 1, 2012, Pages

  Khalili, Hossein ^a   Mohebbi, Niayesh ^a   Hendoiee, Narjes ^a   Keshtkar, Abbas Ali ^b,c   Dashti Khavidaki, Simin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMOXICILLIN; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; FLUOXETINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEW DRUG;

ADVERSE OUTCOME; AGRANULOCYTOSIS; ARTICLE; BRONCHOSPASM; CLINICAL PHARMACY; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; FAX; FOOT EDEMA; HEALTH PERSONNEL ATTITUDE; HUMAN; HYPOGLYCEMIA; INFORMATION SERVICE; INTERVENTION STUDY; IRAN; KNOWLEDGE; MEDICAL INFORMATION SYSTEM; MYALGIA; NORMAL HUMAN; ONLINE SYSTEM; OUTCOME ASSESSMENT; PARESTHESIA; PHARMACIST; RASH; SIDE EFFECT; TEACHING HOSPITAL; TELEPHONE; WEIGHT REDUCTION;

EID: 84859092540     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000367     Document Type: Article

References (24)

1. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to ADR reporting in Iran. Pharm World Sci 2009;31:183-7.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5. (Pubitemid 28193431)
3. Millar JS. Consultation owing to ADR in a single perception. Br J Gen Pract 2001;51:130-1. (Pubitemid 32117821)
4. Figueiras A, Tato F, Fontaiñas J, et al. Physicians' attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract 2001;7:347-54. (Pubitemid 33086243)
5. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond 1995;29:41-9.
6. Vallano A, Cereza G, Pedrõs C, et al. Obstacles and solutions for spontaneous reporting of ADRs in the hospital. Br J Clin Pharmacol 2005;60:653-8. (Pubitemid 41705386)
7. Salehifar E, Ala SH, Gholami KH. Knowledge, attitudes, and perceptions of pharmacists and Nurses ADR reporting in Mazandaran, Iran. Mazandaran University of Medical Science Journal 2007;56:115-25.
8. Fincham JA. Statewide program to stimulate reporting of adverse drug reactions. J Pharm Pract 1989;2:239-44.
9. McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997;44:98-100. (Pubitemid 27296803)
10. Nazario M, Feliu JF, Rivera GC. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience. Hosp Pharm 1994;244:249-50.
11. Cosentino M, Leoni O, Oria C, et al. Hospital-based survey of doctors' attitudes to ADRs and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf 1999;8(Suppl 1):S27-35. (Pubitemid 29201772)
12. Evans SM, Berry JG, Smith BJ, et al. Attitudes and barriers to incident reporting: a collaborative hospital study. Qual Saf Health Care 2006;15:39-43. (Pubitemid 43275524)
13. Bateman DN, Sanders GL, Rawlins MD. Attitudes to ADR reporting in the Northern Region. Br J Clin Pharmacol 1992;34:421-6.
14. Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of ADR reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995;39:223-6.
15. Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of ADR. Br J Clin Pharmacol 1999;48:623-7. (Pubitemid 29454245)
16. Bäckström M, Mjorndal T, Dahlqvist R, et al. Attitudes to reporting ADR in northern Sweden. Eur J Clin Pharmacol 2000;56:729-32. (Pubitemid 32204497)
17. McGettigan P, Feely J. ADR reporting: opinions and attitudes of medical practitioners in Ireland. Pharmacoepidemiol Drug Saf 1995;4:355-8. (Pubitemid 26024672)
18. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol 1997;52:423-7. (Pubitemid 27395640)
19. Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of hospital pharmacists to ADR reporting. Br J Clin Pharmacol 2001;51:81-6. (Pubitemid 32118823)
20. Lee KK, Chan TY, Raymond K, et al. Pharmacists' attitudes toward ADRs reporting in Hong Kong. Ann Pharmacother 1994;28:1400-3.
21. Sweis D, Wong IC. A survey on factors that could affect ADR reporting according to hospital pharmacists in Great Britain. Drug Saf 2000;23:165-72. (Pubitemid 30601403)
22. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about ADR reporting among Rhode Island pharmacists. Ann Pharmacother 1995;29:365-9.
23. Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci 2008;30:556-62.
24. Cosentino M, Leoni O, Banfi F, et al. Attitudes to ADR reporting by medical practitioners in a northern Italian district. Pharmacol Res 1997;35:85-8. (Pubitemid 27207716)